東方支付集團控股(08613.HK)延長配售協議截止日期 配售價更改為每股0.072港元
格隆匯7月23日丨東方支付集團控股(08613.HK)發佈公吿,由於配售代理促使投資者按新配售價認購配售股份及完成有關配售事項的相關行政程序均需額外時間,東方支付與配售代理經公平磋商後已於2021年7月23日交易時段後訂立一份附函,據此,東方支付與配售代理同意以下事項:(i)配售協議項下配售期的屆滿日期由2021年7月23日延長至2021年8月6日;(ii)配售協議的截止日期由2021年7月23日延長至2021年8月6日;及(iii)配售協議項下的配售價由每股配售股份0.07港元更改為每股配售股份0.072港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.